logo
Auto sector reels from China's rare earth restrictions

Auto sector reels from China's rare earth restrictions

The Sun2 days ago

TOKYO: The global auto industry has been rocked by China's decision to restrict exports of rare earth magnets that are crucial to making vehicles.
With a near monopoly on the output of rare earth elements, Beijing is using them as a key weapon in its trade war with Washington.
Here we look at the implications for the sector.
China's restrictions
China accounts for more than 60 percent of rare earth mining production and 92 percent of global refined output, according to the International Energy Agency, driven by generous state subsidies and lax environmental protections.
As the trade war with the United States has developed, Beijing has required Chinese companies since April to obtain a licence before exporting these materials -- including rare earth magnets -- to any country.
While these rules were expected to be relaxed after a tariff deal in Geneva last month, industry stakeholders said they have not been eased at a sufficient pace.
'Since early April, hundreds of export licence applications have been submitted to Chinese authorities, yet only approximately one-quarter appear to have been approved,' the European Association of Automotive Suppliers (CLEPA) said Wednesday.
'Procedures are opaque and inconsistent across provinces, with some licenses denied on procedural grounds and others requiring disclosure of intellectual property-sensitive information.'
And US Treasury Secretary Scott Bessent this month said Beijing was 'blocking certain products it had agreed to market as part of our agreement'.
China, however, defended its 'common international practice'.
Few alternatives
Rare earths are 17 metals used in a wide variety of everyday and high-tech products, from light bulbs to guided missiles.
Two of them -- neodymium and dysprosium -- are crucial to making powerful magnets for electric vehicles and wind turbines.
These components play an essential role in 'electric motors, sensors, power steering, and regenerative braking systems, among other advanced features in modern vehicles', according to consultancy firm BMI.
China's restrictions highlight the world's heavy dependency, with Europe importing 98 percent of its rare earth magnets from the country, BMI said.
And, it notes, while the European Union has introduced regulations to boost its production of critical minerals, 'rare earth processing operations in Europe not only struggle to compete with Chinese producers on cost, but also lack the necessary scale to supply its automotive sector'.
Industry group CLEPA added that efforts undertaken in Europe to diversify supply sources 'offer no short-term solutions and cannot address the acute risks currently facing supply chains'.
Production halts, supply concerns
The auto industry is already suffering globally.
'With a deeply intertwined global supply chain, China's export restrictions are already shutting down production in Europe's supplier sector,' said CLEPA Secretary General Benjamin Krieger.
The group on Tuesday reported 'significant disruptions' in Europe, where these restrictions 'have led to the shutdown of several production lines and plants'. It warned that 'further impacts (were) expected in the coming weeks as inventories deplete'.
'The slow pace of customs formalities for shipments requiring a valid export licence poses a problem,' Hildegard Muller, president of Germany's automotive industry association VDA, told AFP.
'If the situation does not evolve quickly, production delays, or even production losses, can no longer be ruled out.'
While not citing 'direct restrictions' for itself, Germany's Mercedes-Benz said it was maintaining 'close contact' with its suppliers, while Japan's Suzuki Motor said Thursday it 'had ceased production of certain models due to a component shortage', including rare earths, the Nikkei daily reported.
And US auto giant Ford had to halt production for a week in May at its Chicago plant making the Explorer SUV because of shortages, according to Bloomberg.
The firm told AFP that it does not comment on 'supplier issues'.
Indian scooter-maker Bajaj Auto recently warned the restrictions could impact its production in July.
'The slow processing of (export) requests appears to be causing significant supply shortages,' Cornelius Bahr from IW Economic Institute told AFP.
'Statements (by German companies) indicating that stocks will only suffice through the end of June should certainly be taken seriously.'
The electronics industry, another major consumer of rare earths, could also suffer.
'Concern is visibly growing, many companies currently have resources only for a few weeks or months,' said Wolfgang Weber, president of Germany's electronics industry association ZVEI.
Hope for a turnaround
While uncertainty remains, talks between US President Donald Trump and Chinese counterpart Xi Jinping on Thursday seem to have paved the way for a potential easing by Beijing.
'There should no longer be any questions respecting the complexity of (exporting) Rare Earth products,' Trump wrote on his Truth Social platform after their phone call.
A rapid resolution of the China-US row remains unlikely but reports indicate 'an agreement was reached to overcome immediate obstacles, particularly concerning critical minerals', noted Wendy Cutler, vice president of the Asia Society Policy Institute.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China's rare earth dominance reshapes trade war battlefield
China's rare earth dominance reshapes trade war battlefield

New Straits Times

timean hour ago

  • New Straits Times

China's rare earth dominance reshapes trade war battlefield

China has signalled for more than 15 years that it was looking to wea-ponise areas of the global supply chain, a strategy modelled on longstanding American export controls Beijing views as aimed at stalling its rise. The scramble in recent weeks to secure export licences for rare earths, capped by Thursday's telephone call between US and Chinese leaders Donald Trump and Xi Jinping, shows China has devised a better, more precisely targeted weapon for trade war. Industry executives and analysts say while China is showing signs of approving more exports of the key elements, it will not dismantle its new system. Modelled on the United States' own, Beijing's export licence system gives it unprecedented insight into supplier chokepoints in areas ranging from motors for electric vehicles to flight-control systems for guided missiles. "China originally took inspiration for these export control methods from the comprehensive US sanctions regime," said Zhu Junwei, a scholar at the Grandview Institution, a Beijing-based think tank focused on international relations. "China has been trying to build its own export control systems since then, to be used as a last resort." After Thursday's call, Trump said both leaders had been "straightening out some of the points, having to do mostly with rare earth magnets and some other things". He did not say whether China committed to speeding up licences for exports of rare earth magnets, after Washington curbed exports of chip design software and jet engines to Beijing in response to its perceived slow-rolling on licences. China holds a near-monopoly on rare earth magnets, a crucial component in EV motors. In April, it added some of the most sophisticated types to an export control list in its trade war with the US, forcing all exporters to apply to Beijing for licences. That put a once-obscure department of China's commerce ministry, with a staff of about 60, in charge of a chokepoint for global manufacturing. Several European auto suppliers shut down production lines last week after running out of supplies. While China's April curbs coincided with a broader package of retaliation against Washington's tariffs, the measures apply globally. "Beijing has a degree of plausible deniability — no one can prove China is doing this on purpose," said Noah Barkin, senior adviser at Rhodium Group, a China-focused US think tank. "But the rate of approvals is a pretty clear signal that China is sending a message, exerting pressure to prevent trade negotiations with the US leading to additional technology control." Even if the pace of export approvals quickens as Trump suggested, the new system gives Beijing unprecedented glimpses of how companies in a supply chain deploy the rare earths it processes, European and US executives have warned. Other governments are denied that insight because of the complexity of supply chain operations. For example, hundreds of Japanese suppliers are believed to need China to approve export licences for rare earth magnets in coming weeks to avert production disruptions, said a person who has lobbied on their behalf with Beijing. "It's sharpening China's scal-pel," said a US-based executive at a company seeking to piece together an alternative supply chain.. As early as 1992, former Chinese leader Deng Xiaoping was quoted as saying, "The Middle East has oil, China has rare earths". Beijing's landmark 2020 Export Control Law broadened curbs to cover any items affecting national security — from critical goods and materials to technology and data. China has since built its own sanctions power while pouring the equivalent of billions of dollars into developing work-arounds in response to US policies. In 2022, the US put sweeping curbs on sales of advanced semiconductor chips and tools to China over concerns the technology could advance Beijing's military power. But the move failed to halt China's development of advanced chips and artificial intelligence, analysts have said. Beijing punched back a year later by introducing export licences for gallium and germanium, and some graphite products. Exports to the US of the two critical minerals, along with germanium, were banned last December. In February, China restricted exports of five more metals key to the defence and clean energy industries.

US cuts Chinese medicine purchases threefold in April, according to customs data
US cuts Chinese medicine purchases threefold in April, according to customs data

The Star

time3 hours ago

  • The Star

US cuts Chinese medicine purchases threefold in April, according to customs data

MOSCOW, June 8 (Bernama-Sputnik/RIA Novosti) -- The United States drastically cut down the purchase of Chinese medicines in April, with imports in monetary terms showing a threefold drop to US$173.6 million compared to March, RIA Novosti calculations based on US customs data revealed on Sunday. The shipments of Iodine drugs made up the largest share of supplies in April, accounting for 75 per cent of Chinese medicine exports to the US. Additionally, antibiotics (9.5 per cent) and hormonal products (4.4 per cent ) also accounted for significant volumes of shipments in money. The major sellers of drugs to the US in April were India (19 per cent of US imports), Ireland (14 per cent) and Switzerland (13 per cent). China, with a 12 per cent share, ranked 12th, along with Hungary, Denmark and Japan. China and the US are now essentially in a state of trade war, which erupted after US President Donald Trump imposed a 10 per cent tariffs on imports of all Chinese goods in February, raising it to 20 per cent in March. After several reciprocal measures, the US tariff against Chinese goods reached 145 per cent, and the rate for US suppliers to China hit 125 per cent. However, already in mid-May, China and the US mutually reduced trade tariffs to 10 per cent, from May 14 for 90 days. Consequently, China started imposing a 10 per cent tariff on US imports, while the US levied a 30 per cent tariff on Chinese products as the 20 per cent "fentanyl" tariff remained in effect. In late spring, the sides accused each other of violating preliminary agreements. - Bernama-Sputnik-RIA Novosti

US cuts chinese medicine purchases threefold in April
US cuts chinese medicine purchases threefold in April

New Straits Times

time7 hours ago

  • New Straits Times

US cuts chinese medicine purchases threefold in April

MOSCOW: The United States drastically cut down the purchase of Chinese medicines in April, with imports in monetary terms showing a threefold drop to US$173.6 million compared to March, RIA Novosti calculations based on US customs data revealed on Sunday. The shipments of Iodine drugs made up the largest share of supplies in April, accounting for 75 per cent of Chinese medicine exports to the US. Additionally, antibiotics (9.5 per cent) and hormonal products (4.4 per cent ) also accounted for significant volumes of shipments in money. The major sellers of drugs to the US in April were India (19 per cent of US imports), Ireland (14 per cent) and Switzerland (13 per cent). China, with a 12 per cent share, ranked 12th, along with Hungary, Denmark and Japan. China and the US are now essentially in a state of trade war, which erupted after US President Donald Trump imposed a 10 per cent tariffs on imports of all Chinese goods in February, raising it to 20 per cent in March. After several reciprocal measures, the US tariff against Chinese goods reached 145 per cent, and the rate for US suppliers to China hit 125 per cent. However, already in mid-May, China and the US mutually reduced trade tariffs to 10 per cent, from May 14 for 90 days. Consequently, China started imposing a 10 per cent tariff on US imports, while the US levied a 30 per cent tariff on Chinese products as the 20 per cent "fentanyl" tariff remained in effect. In late spring, the sides accused each other of violating preliminary agreements.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store